日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Dasatinib and CAR T-Cell Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Nonrandomized Clinical Trial

达沙替尼联合CAR-T细胞疗法治疗新诊断的费城染色体阳性急性淋巴细胞白血病：一项非随机临床试验

期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2025.0674
Zhang, Mingming; Fu, Shan; Feng, Jingjing; Hong, Ruimin; Wei, Guoqing; Zhao, Houli; Zhao, Mengyu; Xu, Huijun; Cui, Jiazhen; Huang, Simao; Wu, Xiaoyu; Liu, Lianxuan; Sun, Jie; Wu, Wenjun; Zhu, Yuanyuan; He, Jingsong; Zhao, Yi; Cai, Zhen; Zheng, Weiyan; Ye, Xiujin; Shi, Jimin; Luo, Yi; Wang, Dongrui; Chang, Alex H; Hu, Yongxian; Huang, He
T细胞
白血病
T细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Sequential allogeneic HSCT after CAR-T therapy for relapsed/refractory acute lymphoblastic leukemia patients: A long-term follow-up result

CAR-T治疗后复发/难治性急性淋巴细胞白血病患者序贯异基因造血干细胞移植：一项长期随访研究结果

期刊:Journal of Advanced Research
影响因子:13
doi:10.1016/j.jare.2025.02.006
Yang, Tingting; Dong, Yetian; Shi, Jimin; Zhang, Mingming; Kong, Delin; Feng, Jingjing; Fu, Shan; Xiao, Pingnan; Hong, Ruimin; Xu, Huijun; Luo, Yi; Zhao, Yanmin; Yu, Jian; Lai, Xiaoyu; Liu, Lizhen; Fu, Huarui; Ye, Yishan; Cui, Dawei; Cui, Jiazhen; Huang, Simao; Wei, Guoqing; Chang, Alex H; Huang, He; Hu, Yongxian
白血病
细胞生物学
发育与干细胞
干细胞
发表日期：2025
文献求助 收藏

Predictive value of pre-treatment circulating tumor DNA genomic landscape in patients with relapsed/refractory multiple myeloma undergoing anti-BCMA CAR-T therapy: Insights from tumor cells and T cells

治疗前循环肿瘤DNA基因组图谱对接受抗BCMA CAR-T疗法的复发/难治性多发性骨髓瘤患者的预测价值：来自肿瘤细胞和T细胞的启示

期刊:Chinese Medical Journal
影响因子:7.3
doi:10.1097/CM9.0000000000003306
Chen, Rongrong; Jin, Chunxiang; Liu, Kai; Zhao, Mengyu; Yang, Tingting; Zhang, Mingming; Xiao, Pingnan; Feng, Jingjing; Hong, Ruimin; Fu, Shan; Cui, Jiazhen; Huang, Simao; Wei, Guoqing; Huang, He; Hu, Yongxian
肿瘤
T细胞
肿瘤免疫
多发性骨髓瘤
T细胞
骨髓瘤
细胞生物学
肿瘤细胞
免疫/内分泌
发表日期：2025
文献求助 收藏

Safety and efficacy of autologous humanized CD19 CAR-T cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma

自体人源化CD19 CAR-T细胞疗法治疗复发/难治性B细胞非霍奇金淋巴瘤的安全性和有效性

期刊:Bone Marrow Transplantation
影响因子:5.2
doi:10.1038/s41409-025-02691-2
Dong, Yetian; Yang, Tingting; Zhao, Mengyu; Song, Fengmei; Chen, Rongrong; Zhang, Mingming; Hong, Ruimin; Feng, Jingjing; Fu, Shan; Xiao, Pingnan; Xu, Huijun; Cui, Jiazhen; Huang, Simao; Wei, Guoqing; Chang, Alex H; Huang, He; Hu, Yongxian
B细胞
T细胞
淋巴瘤
T细胞
细胞生物学
CD19
免疫/内分泌
发表日期：2025
文献求助 收藏

Relapsed/Refractory Peripheral T-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis With UNC13D and CD27 Germline Mutations

复发/难治性外周T细胞淋巴瘤相关噬血细胞性淋巴组织细胞增生症伴UNC13D和CD27种系突变

期刊:Cell Transplantation
影响因子:3.2
doi:10.1177/09636897231221887
Yang, Tingting; Chen, Rongrong; Zhang, Mingming; Jing, Ruirui; Geng, Jia; Wei, Guoqing; Luo, Yi; Xiao, Pingnan; Hong, Ruimin; Feng, Jingjing; Fu, Shan; Zhao, Houli; Cui, Jiazhen; Huang, Simao; Huang, He; Hu, Yongxian
细胞生物学
T细胞
3D/类器官
免疫/内分泌
CD27
淋巴瘤
T细胞
CD2
发表日期：2024
文献求助 收藏

Safety and efficacy of autologous and allogeneic humanized CD19-targeted CAR-T cell therapy for patients with relapsed/refractory B-ALL.

自体和异体人源化 CD19 靶向 CAR-T 细胞疗法治疗复发/难治性 B-ALL 患者的安全性和有效性

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2022-005701
Song Fengmei, Hu Yongxian, Zhang Yanlei, Zhang Mingming, Yang Tingting, Wu Wenjun, Huang Simao, Xu Huijun, Chang Alex H, Huang He, Wei Guoqing
细胞生物学
Human
细胞基因治疗
发表日期：2023
文献求助 收藏

GDF‑15 prevents LPS and D‑galactosamine‑induced inflammation and acute liver injury in mice

GDF-15 可预防小鼠 LPS 和 D-半乳糖胺诱发的炎症和急性肝损伤

期刊:International Journal of Molecular Medicine
影响因子:5.7
doi:10.3892/ijmm.2018.3747
Min Li, Kui Song, Xiaowen Huang, Simao Fu, Qiyi Zeng
代谢
肝损伤
WB
发表日期：2018
文献求助 收藏